Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Kinaset Therapeutics, Inc.

News headline image
Kinaset Therapeutics Appoints Daniel G. Welch as Board Chair and David Lubner as Independent Director and Audit Committee Chair
From Kinaset Therapeutics, Inc.
Via Business Wire
News headline image
Kinaset Therapeutics Announces $103 Million Oversubscribed Series B Financing to Advance Novel, Inhaled Therapeutic Candidate for Respiratory Diseases
From Kinaset Therapeutics, Inc.
Via Business Wire
News headline image
Kinaset Therapeutics Announces FDA Clearance of IND Application for frevecitinib (KN-002) in Asthma Treatment
From Kinaset Therapeutics, Inc.
Via Business Wire
News headline image
Kinaset Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Kinaset Therapeutics, Inc.
Via Business Wire
News headline image
Kinaset Therapeutics Appoints Christopher O’Brien, MD, PhD, FCCP, as Chief Medical Officer
From Kinaset Therapeutics, Inc.
Via Business Wire
News headline image
Kinaset Therapeutics Announces Dosing Underway in its Phase 1b Study of KN-002 in Healthy Volunteers and Asthma Patients
From Kinaset Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.